Treatment-related neurotoxicity Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Central Nervous System Neoplasms
  • Lymphoma
  • Neurotoxicity Syndromes

abstract

  • Two challenges need to be addressed to improve the outcome of patients with primary central nervous system lymphoma. The first challenge is to develop therapies that result in less toxicity and improved long-term outcome. The second challenge is to develop interventions to help those patients who develop treatment-related neurotoxicity; ongoing collaborative efforts are required to improve communication and understanding of this complication. Long-term follow up of prospective therapeutic studies should report on both disease control and the development of neurotoxicity. New protocols should include prospective longitudinal measures of neurocognitive function.

publication date

  • August 2005

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.hoc.2005.05.010

PubMed ID

  • 16083833

Additional Document Info

start page

  • 729

end page

  • 38, viii

volume

  • 19

number

  • 4